USBC, Inc. 8-K

What Happened

• On April 27, 2026, USBC, Inc. drew an additional fixed-rate borrowing of $5.0 million (the "Second Draw") under its Master Loan Agreement (MLA) with Payward Interactive dated March 18, 2026. The Second Draw brings the aggregate principal outstanding under the MLA to $10.0 million. The borrowing bears interest at 8.5% per annum and matures on April 27, 2027, unless earlier terminated. Borrowings under the MLA are secured solely by Bitcoin collateral held in custody with Payward Financial, Inc., and are subject to customary margin requirements and liquidation rights.
• Separately, on March 10, 2026, USBC announced the initiation of Phase 1 of its multi‑phase delivery strategy for its tokenized deposit product. Phase 1 is a limited internal test of onboarding, identity recovery, ACH funding, spending, treasury conversion, messaging, and activity logging. Development activity is advancing with third‑party vendors and affiliated services provided under an Affiliate Services Agreement with Vast Holdings, Inc.; as of April 30, 2026, USBC has reimbursed Vast approximately $3.5 million of development costs under a $10.5 million cap (Agreement expires December 31, 2026).

Key Details

• $5.0M Second Draw on April 27, 2026; aggregate MLA outstanding now $10.0M.
• Interest rate: 8.5% per annum; maturity April 27, 2027.
• Loan collateral: Bitcoin held with Payward Financial; subject to margin maintenance and liquidation rights.
• Tokenized deposit Phase 1 began March 10, 2026; ~$3.5M reimbursed to Vast through April 30, 2026 (cap $10.5M; Agreement expires 12/31/2026).

Why It Matters

• The new borrowing increases USBC’s funded debt and near‑term interest expense (8.5% rate) and is secured by Bitcoin, which can introduce margin‑call and liquidation risks if collateral values fall. Investors should monitor collateral levels, margin requirements, and any additional draws (the MLA allows up to $25.0M aggregate borrowings subject to term sheets).
• Progress on the tokenized deposit product shows technical testing is underway but remains in internal Phase 1; there is no retail launch date yet. Development costs are accelerating (already ~$3.5M reimbursed to an affiliate), which could affect cash flow and operating results in the near term. The filing also includes standard forward‑looking statement disclosures about timing, regulatory, and execution risks.